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Purpose: This study examined whether the 
addition of biomarkers presepsin (PSEP), 
procalcitonin (PCT) and C-reactive pro-
tein (CRP) to the initial SOFA (iSOFA) 
score can improve diagnostic accuracy of 
early sepsis diagnosis in emergency ab-
dominal surgery patients.
Materials and Methods: Seventy-two study 
subjects had diagnosis of acute abdomen 
due to gastrointestinal disturbances.  The 
study evaluated diagnostic accuracy and 
predictive value of two models (iSOFA 
only and iSOFA combined with three bio-
markers) for sepsis diagnosis.
Results:  The AUC value for the iSOFA 
was highest, followed by the AUC value 
obtained for PSEP, PCT and CRP (0.989, 
0.738, 0.694 and 0.606, respectively).The 
logistic regression analysis of the two mod-
els showed for the first model that patients 
with a higher iSOFA score are almost two 
times more likely to suffer from sepsis. In 
the second model, patients with a higher 
iSOFA score and a higher level of biomark-
ers are three times more likely to have sep-
sis.
Conclusions: Although the SOFA score is 
known to be the best diagnostic tool for 
sepsis diagnosis, it seems that among the 
three investigated markers PSEP and PCT– 
although not contributing to the iSOFA 
score– are good independent markers with 
significantly higher levels in septic than in 
non-septic patients. PSEP has the highest 
diagnostic accuracy for sepsis. Only the 
conventional marker CRP provides certain 
added value to the iSOFA score for sepsis 
prediction. 
Further investigations should be per-
formed to study the possible diagnostic 
value of dynamic changes of the three ex-
amined markers in prediction and early 
diagnosis of sepsis.
Keywords: Sepsis, SOFA, presepsin, procal-
citonin, abdominal surgery
INTRODUCTION
Sepsis and septic shock in abdominal sur-
gical patients develop as a consequence 
of intra-abdominal (IAI) or surgical site 
infections and can be termed abdominal 
sepsis. In emergency surgical patients, 
morbidity and mortality are higher than in 
non-emergency surgical patients (1). The 
major risk factors for development of sep-
sis and septic shock and consequent deaths 
are age, emergency surgery, presence of 
different comorbidities and gender (male) 
(2). According to the Third International 
Consensus definition of sepsis and septic 
shock (Sepsis-3), sepsis diagnosis is made 
when there is an acute change in the  to-
tal SOFA score of ≥ 2 points consequent to 
infection, and patients with septic shock 
are diagnosed by using a clinical construct 
of sepsis with persisting hypotension that 
requires vasopressors to maintain mean 
arterial pressure (MAP) 65 mmHg; also, 
septic shock patients have a serum lactate 
level >2 mmol/L despite adequate volume 
resuscitation (3). As the key to successful 
sepsis treatment lies in the early recogni-
tion followed by appropriate therapy and 
infection source control, early identifica-
tion of sepsis is challenging and the identi-
fication of patients at highest risk for sepsis 
development is very important (4,5).
The diagnosis of infection is confirmed 
by microbiological findings that, however, 
have some serious limitations: they are 
time-consuming and can be false negative. 
Therefore, biochemical markers of infec-
tion/inflammation could help to not only 
detect an infection but to detect a failed 
source control. The traditionally used 
biomarkers of infection/inflammation 
are C-reactive protein (CRP), procalci-
tonin (PCT) and, in recent time, presepsin 
(PSEP). 
This study was conducted in order to ex-
amine whether the addition of biomarkers 
of inflammation/infection PSEP, PCT and 
CRP to the initial SOFA (iSOFA) scoring 
system can improve diagnostic accuracy 
of early sepsis diagnosis in emergency 
abdominal surgery patients. The specific 
aims were as follows:
a) To determine the cut-off values 
of PSEP, PCT and CRP whose sensitivity 
to sepsis after adding to the iSOFA scoring 
system is ≥95% and specificity is the high-
est possible with such sensitivity rate. 
b) To determine regression coef-
ficients for the three markers in order to 
make their diagnostic value highest after 
the addition to the iSOFA score.
 
MATERIALS AND METHODS
The study protocol was approved by the 
University Hospital Centre Zagreb Ethics 
Committee and the Faculty of Pharmacy 
and Biochemistry Ethics Committee. Pa-
tients gave their written informed consent 
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for participation in the study. The study 
was designed and executed in accordance 
with World Medical Association Declara-
tion of Helsinki 2013.
Study population
We performed a unicentric, prospec-
tive, cross-sectional, applied study. The 
required sample size of 72 (36 septic and 
36 non-septic) patients was calculated us-
ing data from Yang Y et al. (6). The sample 
size was calculated using PASS 14 Power 
Analysis and Sample Size Software (2015), 
NCSS, LLC. Kaysville, Utah, USA, ncss.
com/software/pass. To include 36 abdomi-
nal septic patients required for statistical 
analysis, 244 samples of abdominal emer-
gency patients admitted postoperatively to 
the 13-bed general surgical intensive care 
unit (ICU), University Hospital Centre 
Zagreb, were collected from October 2015 
to April 2017. The criteria for enrolment 
were the following: age between 50 and 
80, acute abdomen diagnosis caused by 
gastrointestinal inflammatory processes, 
intestinal obstructions and ileus, dehis-
cence of a surgical wound, gastrointestinal 
anastomosis or gastrointestinal perfora-
tion. The exclusion criteria were immuno-
suppressive therapy, and hemato-oncology 
or general oncology patients with ongoing 
chemotherapy because of high possibility 
of immune modulation. The admission to 
the ICU depended on comorbidity, initial 
surgical diagnosis, complexity of surgical 
procedure, intraoperative findings, hemo-
dynamic stability during surgical proce-
dure and general condition of a patient. 
Before surgery, standard antimicrobial 
prophylaxis (combination of antibiotics 
metronidazol and cefazolin or metronida-
zol and ciprofloxacin) was administered to 
all patients.
Outcome
Patients were classified according to the 
endpoint, i.e. sepsis. The frequent occur-
rence of primary sepsis in patients under-
going surgical treatment emphasizes the 
importance of evaluation within first five 
days. The maximum of five days was cho-
sen because the median ICU length of stay 
(LOS) for septic and non-septic patients 
was six (IQR 3-12) and two (IQR 1-4) days, 
respectively. Sepsis was diagnosed on the 
basis of the third consensus definition for 
sepsis and septic shock plus the presence 
of either documented or suspected infec-
tion (3). Suspected infection means that a 
patient had either negative microbiological 
tests or there were no microbiological tests 
requested, but there were clinical signs 
present such as fever, positive radiologi-
cal findings, intra-abdominal presence of 
pus and cloudy fluid, gut perforation and 
peritonitis stercoralis during surgical pro-
cedure.
According to the criteria mentioned above, 
two independent study physicians classi-
fied patients into the following two groups: 
1. 36 patients with abdominal sepsis (SE)
2. 36 patients without abdominal sepsis 
(NSE) with or without infection.
Sampling, laboratory analysis and SOFA 
calculation
Lithium-heparin blood samples were col-
lected 12 hours after surgery for CRP, PSEP 
and PCT determination. For diagnosis of 
sepsis and septic shock, the SOFA score 
was calculated perioperatively (iSOFA) 
and every 24 hours postoperatively dur-
ing five or less postoperative days depend-
ing on patient condition and ICU length 
of stay. The Δ-SOFA score was the differ-
ence between the highest/lowest 24-hour 
score and admission score. The clinical 
and laboratory parameters for the SOFA 
calculation were determined each day as 
part of morning routine assessment us-
ing the SOFA calculator (7). Infection was 
confirmed by microbiological examination 
of samples from the sources that should be 
physiologically sterile (abdominal intra-
operative specimen and hemoculture) 
and/or surgical wound samples. Accord-
ing to the clinical status of a patient and 
attending surgeon`s estimate, microbio-
logical examination was not performed 
for low-risk patients. PSEP was measured 
by using the PATHFAST PSEP kit based 
on chemiluminescent enzyme immunoas-
say on the PATHFAST Immunoanalyser. 
PCT was determined by the ELECSYS+ 
BRAHMS+ PCT assay based on electro-
chemiluminescent immunoassay and CRP 
was measured by immunoturbidimetry on 
Cobas ce6000 analyser.
Statistical analysis
Statistical significance was determined at 
P<0.05 level. The hypothesis that a combi-
nation of PSEP, PCT, CRP and SOFA scor-
ing system will have a better diagnostic 
accuracy for the early sepsis recognition 
than the SOFA score alone was checked 
by one-tail Spearman`s correlation. Devia-
tion from Gaussian distribution was tested 
by Shapiro-Wilk test. Nonparametric data 
were expressed as median and interquar-
tile range (25th-75thIQR). The Mann-
Whitney test was used as nonparametric 
test for comparison of continuous vari-
ables. Diagnostic accuracy was expressed 
as sensitivity, specificity, area under the re-
ceiver operating curve (ROC) and positive 
and negative likelihood ratios. The cut-off 
values were determined at 95% sensitivity 
and the highest possible specificity with 
this sensitivity rate. Multivariate logistic 
regression was used to determine regres-
sion coefficients according to presence or 
absence of sepsis as a dependent variable. 
The compatibility of the final model with 
empirical data was checked by the Hos-
mer-Lemeshow test, and its statistical sig-
nificance by Omnibus test. The total value 
of the model was expressed by the Nagel-
kerke pseudo coefficient of determination 
(R2) and the total proportion of correctly 
diagnosed patients. The relationship be-
tween PSEP and kidney function param-
eters, estimated glomerular filtration rate 
(eGFR) was determined by two-tailed 
Spearman`s correlation. Statistical analysis 
was performed using the SPSS statistical 
program, version 25 (SPSS Inc, Chicago, 
IL, USA).
RESULTS
Characteristics of patient population 
and microbiological findings
Study subjects were fairly homogenous 
and all had diagnosis of acute abdo-
men due to gastrointestinal disturbances. 
Study patients’ data are shown in Table 1. 
In the SE and NSE, the median (min to 
max) age was 69 (56-79) and 70 (53-80), 
respectively. There were no statistical dif-
ferences between the number of male and 
female subjects in the two groups (22 vs 
21, respectively, p=1.000). Based on the 
two most frequently established diagnoses, 
the two groups differed statistically signifi-
cantly. Perforation/dehiscence diagnosis 
had 22 septic and 9 non-septic patients. 
Ileus diagnosis had 10 septic and 16 non-
septic patients, p=0.018.   Microbiologi-
cal studies showed that in the NSE there 
were negative microbiological findings in 
9/18 patients, while no microbiological 
examinations were performed in 18/36 
patients. In the SE group, no microbiologi-
cal examinations were performed in 2/36 
patients and microbiological examina-
tions were negative in 3/34 patients. Veri-
fied infections were mostly caused by both 
gram-positive and gram-negative bacteria 
(21/34). The length of stay in the intensive 
care unit was more pronounced in septic 
patients than in NSE patients (6 versus 2 
days, p <0.001). There was no statistical 
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difference in lethal outcomes on day 28 
between SE and NSE patients (7/36 and 
1/36, respectively, p=0.055). Table 2 shows 
the sites from which samples were taken 
for microbiological analysis. One lethal 
outcome in the NSE group was caused by 
cardiorespiratory arrest; there was no in-
fection or sepsis. 
Comparison of the iSOFA score and 
three biochemical markers between the 
two groups of patients
The median and IQR for four parameters 
of the two patient groups are shown in Ta-
ble 3, Figure 1 (A-D). The Mann-Whitney 
test showed significant differences between 
SE and NSE group in the iSOFA score, 
PSEP and PCT [SE 10(IQR 8-12) and NSE 
1(IQR 1-2), p<0.001; SE 1121.5(IQR 462.5-
2265.0) and NSE 525.5(IQR 269.8-696.0), 
p<0.001; SE 2.96(IQR 1.80-23.78) and NSE 
0.75(IQR 0.30-9.30, p=0.005], respective-
ly. There was no significant difference in 
CRP (SE 151.1(IQR 63.4-282.3) and NSE 
101.4(IQR 36.5-225.9), p=0.120). In the 
NSE group, there was one extreme outlier 
in PSEP measurement (11089 ng/L). This 
result was not removed from statistical 
analysis because it was not the measure-
ment error and there was no difference in 
statistical analysis when this case was ex-
cluded.
Diagnostic accuracy and cut-off values 
of PSEP, PCT and CRP combined with the 
iSOFA score
One-tailed Spearman's correlation for 
verification of the main hypothesis shows 
that there is a statistically significant cor-
Table1. Characteristics of 72 studied patients
SEPTIC NON-SEPTIC Statistical significance (P)
N (number of patients) 36/7a 36





















































ICU LOS (days) 6 (1-125b/3-12c) 2 (1-8b/1-4c) <0.001*
Outcome (28-day mortality) 0.055
YES 7 1d
NO 29 35
a Septic shock developed in seven patients
b Minimum and maximum value
c Interquartile range (25th-75th)
d Lethal outcome caused by cardiorespiratory arrest; not infection- nor sepsis-related
Mann-Whitney test was used to examine statistically significant difference between two groups according to age and ICU LOS, and 
Fisher`s exact test according to gender, clinical diagnosis and outcome.




1-Intraoperative specimen 6 20
2-Hemoculture 0 7
3-Surgical swab 2 5
4-Minilavate 1 1
5-Tracheal aspirate 4 1
6-Surgical drain 1 0
7-Other swab 4 0
       SIGNA VITAE    |    41
relation between the iSOFA score and two 
markers, PSEP and PCT (Spearman`s rho 
0.363, p=0.001 and Spearman`s rho was 
0.354, p<0.001). There was no significant 
correlation between the iSOFA score and 
CRP, p = 0.239, as shown in Table 4. ROC 
analysis was performed to assess diagnostic 
accuracy for four parameters. The results 
showed that the AUC value for the iSOFA 
was highest, followed by the AUC value 
obtained for PSEP, PCT and CRP [0.967 
(95% CI 0.925-1.000), p<0.001; 0.738 (95% 
CI 0.623-0.853), p=0.001; 0.694 (95% CI 
0.571-0.817), p=0.005; 0.606 (95% CI 
0.476-0.737), p=0.120], respectively. The 
cut-off values of SOFA, PSEP and PCT for 
diagnosing sepsis with 95% sensitivity and 
the highest possible specificity with such 
sensitivity rate were 2 points, 349 ng/L and 
0.17 µg/L, respectively (Table 4 and Figure 
2).
Multiple logistic regression analysis of 
the iSOFA score by adding PSEP, PCT 
and CRP
Logistic regression analysis was performed 
to assess the impact of markers on the 
likelihood that a patient has sepsis. There 
are two models: the first contained one 
independent variable (iSOFA score) and 
the second contained four independent 
variables (iSOFA score, PSEP, PCT and C-
reactive protein).  The first and the second 
model were both statistically significant, χ2 
(1, N=72) = 70.5, p<0.001 and χ2 (4, N=72) 
= 81.4, p<0.001, respectively, indicating 
that the models are able to distinguish SE 
from NSE. The second model was better in 
discriminating the two groups of patients. 
Hosmer and Lemeshow test also supports 
both models as reliable, first model χ2 (6) 
= 1.27, p=0.974 and second model χ2 (6) = 
2.46, p=0.963. The models explained 83% 
and 90% of the variance of sepsis diagnosis 
and correctly classified 92% and 96% cases, 
respectively, Table 5. As shown in Table 6, 
the SOFA score is the strongest predictor 
of sepsis and, of the three markers, only 
CRP contributes statistically significantly 
to the model. The odds ratio for the SOFA 
score in the first model is 2.304 (95% CI 
1.583-3.354, p<0.001) and in the second 
model 3.22 (95% CI 1.696-6.102, p<0.001). 
These results indicate that patients with the 
higher initial SOFA score without markers 
are 2.3 times more likely to have sepsis, and 
patients with the higher initial SOFA score 
and simultaneously obtained high concen-
tration of three markers are 3.2 times more 
likely to have sepsis. 
The regression equation obtained for the 
second model is as follows:
SEPSIS= -8.988 + 1.17(SOFA) + 0.015 
(CRP)
Correlation of PSEP and the kidney func-
tion parameters
The results showed statistically signifi-
cant negative correlation between PSEP 
and eGFR, Spearman`s rho was -0.593, 




Despite the last Sepsis-3 definition which 
confirms that changes in the SOFA score 
form the basis of sepsis diagnosis (3), the 
routine use of biochemical markers of in-
fection/inflammation are nevertheless of 
great help in the early recognition, risk 
Table 3. The median and 25th-75th IQR for four parameters in the two groups of patients






















































iSOFA – initial sequential organ failure assessment
PSEP – presepsin 
PCT – procalcitonin
CRP – C-reactive protein 
Table 4. Diagnostic accuracy of four markers for sepsis diagnosis
AUC P 95% Confidence 
Interval




iSOFA 0.967 <0.001* 0.925 - 1.000 2 point 0.972 0.528 2.051 0.053
PSEP 0.738 0.001* 0.623 - 0.853 349 0.972 0.333 1.460 0.084
PCT 0.694 0.005* 0.571 - 0.817 0.17 0.972 0.167 1.167 0.168
CRP 0.606 0.120 0.476 - 0.737 18.1 0.972 0.139 1.129 0.201
*ROC analysis 
iSOFA – initial sequential srgan failure assessment
PSEP – presepsin 
PCT – procalcitonin
CRP – C-reactive protein 
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stratification and therapy monitoring. The 
principal aim of this study was to investi-
gate whether the well-established routine 
markers PCT and CRP (8), along with 
the newly introduced PSEP, could provide 
added value, together with the initial SOFA 
score, for the prediction and early diag-
nosis of sepsis in emergency abdominal 
surgery patients admitted to the general 
surgical ICU. In accordance to our specific 
aim the initial SOFA score was used as a 
helping tool for early sepsis diagnosis de-
spite defined SOFA score changes as a pa-
rameter on which the diagnosis of sepsis is 
based (3).
As the early identification of patients at 
risk for sepsis development is crucial in 
order to confirm and remove the infec-
tious source as soon as possible, a broad 
spectrum of antimicrobial therapy should 
be administered to stop spreading the 
infection (4,9,10). In this study we meas-
ured perioperative PSEP, PCT and CRP 
as markers of infection/inflammation and 
evaluated their diagnostic accuracy, the ac-
curacy of the initial SOFA score separately 
and of the combination of all aforemen-
tioned parameters for sepsis diagnosis. To 
the best of our knowledge, previous studies 
did not investigate these four markers to-
gether in the specific population of emer-
gency abdominal surgery patients. 
The study revealed that the initial SOFA 
score, PSEP and PCT were significantly 
higher in septic than in non-septic group 
of patients, which is in accordance with 
previous studies (11–14). The CRP was not 
significantly different in the two groups 
of patients, as was already seen in other 
studies with similar patient population 
(15,16). Santonocito C et al. reported dif-
ferent results but they studied a different 
patient population and, unlike our study, 
examined postoperative CRP changes 
(17). With regard to our chosen sepsis sen-
sitivity threshold of ≥ 95%, the obtained 
cut-off value for the iSOFA score was two 
points. The AUC was 0.967 and specificity 
53%. Other studies have not shown so high 
AUC for the SOFA score (6,18,19) prob-
ably because heterogeneous patient popu-
lations were involved, as opposed to our 
study which comprised fairly homogenous 
patient population.  The obtained speci-
ficity for iSOFA was pretty low. However, 
compared with specificity obtained for 
other three markers it could be concluded 
that iSOFA was a parameter with the high-
est specificity for sepsis. 
The logistic regression analysis of two 
models, the first including only the iSOFA 
score and the second combining three bio-
markers and the iSOFA score, showed that 
Table 5. Total value of models in distinguishing SE from NSE patients
A)












Overall percentage   91.7
B)












Overall percentage   95.8
Logistic regression: A) First  model is based only on the initial SOFA score, B) Second model  takes into account all four markers
Table 6. Logistic regression predicting likelihood of sepsis
95% Confidence interval for OR
FIRST MODEL B p OR Lower Upper
iSOFA 0.835 <0.001* 2.304 1.583 3.354
SECOND MODEL B p OR Lower Upper
iSOFA 1.168 <0.001* 3.217 1.696 6.102
PSEP 0.000 0.225 3.217 1.000 1.001
PCT -0.016 0.605 0.984 0.925 1.046
CRP 0.015 0.001* 1.015 1.003 1.028
iSOFA – initial sequential organ failure assessment
PSEP – presepsin 
PCT – procalcitonin
CRP – C-reactive protein
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–of three biomarkers– only CRP contrib-
uted statistically significantly to the diag-
nostic performance of the model involving 
only iSOFA score. For the first model, the 
analysis showed that patients with a higher 
SOFA score are almost two times more 
likely to suffer from sepsis. In the sec-
ond model, patients with a higher iSOFA 
score and a higher level of biomarkers are 
two times more likely to have sepsis. The 
first model was shown to correctly clas-
sify 91.7% patients and the second model 
95.8% patients. This means that, out of one 
hundred patients, we can diagnose sepsis 
in four additional patients using the sec-
ond model with added biochemical mark-
ers. The logistic regression for the second 
model showed that PSEP and PCT do not 
contribute to the model at all. But CRP, 
which has by itself been shown as unable 
to distinguish a septic from non-septic 
patient, provides additional value for the 
SOFA score in our model.
Regardless of the fact that the biochemi-
cal markers do not contribute statistically 
significantly to the iSOFA score, we deter-
mined the cut-off values of each marker 
bearing in mind our specific aim. For the 
desired sensitivity of ≥ 95%, the obtained 
cut-off values for sepsis were: PSEP 349 
ng/L, PCT 0.17 μg/L and CRP 18.1 mg/L. 
PSEP showed a slightly higher diagnostic 
accuracy than PCT (AUC 0.738 vs. 0.694). 
It was shown that CRP with AUC 0.606 
cannot distinguish septic from non-septic 
patients. Specificity for all three markers 
PSEP, PCT and CRP was fairly low, i.e. 
33%, 17% and 14%, respectively. 
The determined cut-off values for PSEP 
and PCT are near the upper reference limit 
(20–22). These low cut-off values are the 
consequence of our specific aim which in-
volved high sensitivity and thus early sep-
sis recognition. Similar results and a fairly 
low cut-off value for CRP were obtained 
by Meyer ZC et al. when they examined 
dynamic changes of CRP during the ICU 
course (23). In this study there was one 
patient within the control group with an 
extremely high PSEP value (11.089 ng/L) 
together with very high PCT and CRP val-
ues (35.64 μg/L and 169.0 mg/L, respec-
tively). Those results were not removed 
from statistical analysis because there was 
no question of error in the patient identi-
fication and measurement. Unfortunately, 
the microbiological examination was not 
done for this patient and we do not know 
if there was any infection. This patient 
suffered from liver dysfunction with low 
cholinesterase activity, renal insufficiency 
and COPD. A study from Papp et al. (24) 
showed that PSEP is a useful infection 
marker in liver disease but in renal failure 
the PSEP level increases as the glomerular 
filtration rate (GFR) decreases (24–26). 
Masson et al. have shown that high levels 
of PSEP can be found in COPD patients 
(27). Inflammatory/infection markers can 
be increased in patients with COPD ex-
acerbation (28) but this was not the case 
with their patient. The patient was classi-
fied in the non-septic group according to 
the SOFA score (one point), spent only one 
day in ICU, was discharged from hospital 
after five days and was alive after 28 days. 
The suspicion remains that the patient still 
had infection but it has never been proven. 
The examined correlation of PSEP with 
the estimated GFR in this study showed 
inverse connection. This is the reason why 
Figure 1. Levels of four markers in SE and NSE group
A) presepsin, B) procalcitonin, C) C-reactive protein and D) initial SOFA score. Lines across inside the box represent median values and 
whiskers represent minimum and maximum values. The reference lines to the y axis represent cut-off values obtained according to the 
specific aim.
iSOFA – initial sequential organ failure assessment, PSEP – presepsin , PCT – procalcitonin, CRP – C-reactive protein
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the interpretation of PSEP values must be 
related to the kidney function. 
Our study consists of consecutively includ-
ed patients as they were admitted postop-
eratively to the surgical ICU. No healthy 
subjects were included in the study as a 
control group, and the markers used (ex-
cept PSEP) are part of the actual routine 
practice in the general surgical ICU. Also, 
although this is a study with small sample 
size, it was designed to minimize patient 
heterogeneity.
LIMITATIONS
The main limitation of this study, besides 
relatively small sample size and unicen-
tricity, is the fact that the microbiological 
examinations were not done in all patients 
and therefore there are no complete data 
for each patient about the presence or ab-
sence of infection.   
CONCLUSION
The SOFA score is known to be the best 
diagnostic tool for sepsis diagnosis, but it 
seems that PSEP and PCT are among the 
three investigated markers –although not 
contributing to the iSOFA score– good 
independent markers with significantly 
higher levels in septic than in non-septic 
patients. PSEP has the highest diagnostic 
accuracy for sepsis. Only the conventional 
marker CRP provides certain added value 
to the iSOFA score for sepsis prediction. 
Further investigations should be per-
formed to study the possible diagnostic 
value of dynamic changes of the three ex-
amined markers in prediction and early 
diagnosis of sepsis.
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